<DOC>
	<DOCNO>NCT01907061</DOCNO>
	<brief_summary>Trial test effect administer N-acetylcysteine cytokine marker oxidant stress incidence acute renal failure post liver tranplant</brief_summary>
	<brief_title>Acute Renal Failure Post Liver Transplantation</brief_title>
	<detailed_description>1 . To determine level pro-inflammatory cytokine oxidative stress marker liver transplant patient post-transplant period 2 . To correlate change pro-inflammatory cytokine marker oxidative stress acute renal failure acute rejection 3 . To determine impact use N-acetylcysteine cytokine marker oxidative stress incidence acute renal failure post liver transplantation</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>First liver transplant Normal renal function transplantation [ serum creatinine â‰¤ 1.5 mg / dl ] No requirement dialysis transplantation Age great 18 year Retransplant Renal dysfunction i.e . serum creatinine &gt; 1.5 mg/dl Need dialysis transplantation Presence Hepatorenal Hepatopulmonary syndrome* Combined liver kidney transplant Peptic ulcer disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>71 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>acute renal failure</keyword>
	<keyword>post liver transplant</keyword>
</DOC>